...
首页> 外文期刊>Protein Expression and Purification >A PCR-directed cell-free approach to optimize protein expression using diverse fusion tags
【24h】

A PCR-directed cell-free approach to optimize protein expression using diverse fusion tags

机译:使用PCR指导的无细胞方法,使用多种融合标签优化蛋白质表达

获取原文
获取原文并翻译 | 示例

摘要

N-terminal fusion tags that enhance translation initiation or protein solubility are often used to facilitate protein overexpression. As the optimal tag for a given target protein cannot be predicted a priori, valuable time can be lost in cloning and manipulating the corresponding gene to generate different fusion constructs for expression analysis. We have developed a cell-free strategy that consolidates these steps, enabling the utility of a panel of nine fusion-tags to be determined within one to two days. This approach exploits the fact that PCR-amplified DNA can be used as a template for cell-free protein synthesis. Overlap/extension PCR using the TEV protease site as the overlap region allows the fusion of different T7 promoter (T7p)-tag-TEV DNA fragments with a TEV-gene-T7 terminator (T7ter) fragment. For tag sequences where the TEV site is not compatible, a short C_3G_3 repeat (CGr) sequence can be used as the overlap region. The resulting T7p-tag-TEV-gene-T7ter constructs are then used as templates for PCR-directed cell-free protein synthesis to identify which tag-TEV-gene fusion protein produces the highest amount of soluble protein. We have successfully applied this approach to the overexpression of the Adiponectin hypervariable domain (AHD). Five of the nine N-terminal fusion tags tested enabled the synthesis of soluble recombinant protein. The best of these was the Peptidyl-prolylcis-trans isomerise B (PpiB) fusion tag which produces 1 mg/ml amounts of soluble fusion protein. PpiB is an example of a new class of fusion tag known as the "stress-responsive proteins". Our results suggest that this cell-free fusion-tag expression screen facilitates the rapid identification of suitable fusion-tags that overcome issues such as poor expression and insolubility, often encountered using conventional approaches.
机译:增强翻译起始或蛋白质溶解度的N末端融合标签通常用于促进蛋白质过表达。由于无法事先预测给定目标蛋白的最佳标签,因此克隆和操纵相应基因以生成用于表达分析的不同融合构建体时,可能会浪费宝贵的时间。我们已经开发出一种无细胞策略,可以整合这些步骤,从而在一到两天内确定9个融合标签组的实用性。这种方法利用了PCR扩增的DNA可以用作无细胞蛋白质合成模板的事​​实。使用TEV蛋白酶位点作为重叠区的重叠/延伸PCR允许将不同的T7启动子(T7p)-tag-TEV DNA片段与TEV基因-T7终止子(T7ter)片段融合。对于TEV位点不兼容的标签序列,可以将短C_3G_3重复(CGr)序列用作重叠区域。然后将所得的T7p-tag-TEV-基因-T7ter构建体用作PCR指导的无细胞蛋白合成的模板,以鉴定哪种标签-TEV-基因融合蛋白产生最高量的可溶性蛋白。我们已经成功地将这种方法应用于脂联素高变域(AHD)的过表达。测试的九个N末端融合标签中有五个能够合成可溶性重组蛋白。其中最好的是肽基-脯氨酰-反式异构体B(PpiB)融合标签,可产生1 mg / ml量的可溶性融合蛋白。 PpiB是一类新的融合标签的例子,称为“应激反应蛋白”。我们的结果表明,这种无细胞的融合标签表达筛选有助于快速鉴定合适的融合标签,从而克服了常规方法经常遇到的表达不佳和不溶性等问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号